Stay updated with breaking news from Follow up results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease, Compared to the Placebo Arm; Data Support ....
/PRNewswire/ Monte Nido & Affiliates, one of the leading eating disorder therapy providers in the country, recently published groundbreaking research. ....
/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM platform, announced the results from its PADN series study during the Late-Breaking Clinical. ....